Mentice AB (MN2) AI Stock Analysis

Mentice AB

(Frankfurt:MN2)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Improving revenue trajectoryStronger TTM revenue growth indicates improving demand for Mentice’s simulation and training offering. If sustained, broader adoption across hospitals, training centers, and medical device customers can support operating leverage and provide a durable foundation for future earnings improvement.

Negative Factors

Persistent operating lossesMentice has improved its profitability trend but has not yet reached consistent bottom-line profitability. Continued EBIT and net losses can limit internally funded growth, weaken returns on invested capital, and make future performance more dependent on successful execution and revenue expansion.

Mentice AB (MN2) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 39.59M
Dividend Yield: ―
Average Volume (3M): 820
Price to Earnings (P/E): -90.5
Beta (1Y): 0.94
Revenue Growth: 19.88%
EPS Growth: 91.59%
Country: Germany
Employees: 109
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Mentice AB Business Overview & Revenue Model

Company Description

Mentice AB (publ), founded in 1998 and headquartered in Gothenburg, Sweden, specializes in delivering advanced endovascular simulation solutions. These are utilized by educational institutions, healthcare systems, and medical device manufacturers glo...

Mentice AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:MN2 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:SECT.B	79Outperform	SEK 67.51B	105.81	30.26%	0.38%	13.94%	5.70%
SE:GETI.B	67Neutral	SEK 75.64B	26.73	9.13%	1.71%	-3.90%	37.73%
SE:XVIVO	64Neutral	SEK 6.46B	50.12	5.89%	―	17.83%	330.94%
SE:BACTI.B	53Neutral	SEK 560.70M	88.89	1.93%	―	-0.51%	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:HEART	47Neutral	SEK 142.76M	-2.37	-54.68%	―	―	―

* Healthcare Sector Average

Performance Comparison

DE:MN2 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:MN2	Mentice AB	1.37	0.49	56.04%
SE:GETI.B	Getinge AB (UK)	277.70	60.83	28.05%
SE:XVIVO	Xvivo Perfusion AB	205.00	22.50	12.33%
SE:BACTI.B	Bactiguard Holding AB	16.00	-1.00	-5.88%
SE:SECT.B	Sectra AB Class B	346.00	49.17	16.56%
SE:HEART	Scandinavian Real Heart AB	16.80	1.31	8.43%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Mentice AB AI Stock Analysis